[PDF] Top 20 Neurodegeneration in systemic lupus erythematosus

... Systemic lupus erythematosus (SLE) is a chronic auto- immune disease that can affect multiple organ ...occurs in 12% to 95% of patients with SLE [ 1 ...neuropsychiatric systemic ... See full document

... mortality in SLE patients, with an early death due to active disease and infections, and a late death secondary to ...reduction in SLE mortality over the years, CVD remains prevalent among these patients, ... See full document

... e Systemic Lupus Erythematosus Disease Activity Index -2K foram correlacionados com a presença e grau de dano medido pelo índice Systemic Lupus International Collaborating ... See full document

... detected in systemic lupus erythematosus (SLE) ...polymorphisms in the ABCB1 gene. Therefore, their frequencies were determined in Brazilian individuals with European ancestry (N ... See full document

... the lupus features such as malar rash, discoid rash, pho- tosensitivity, oral ulcer, non-erosive arthritis, serositis, renal disorder, neurological disorder, hematological disorder (including presence of anemia, ... See full document

... heterogeneity in clinical manifestations and disease course ...advances in understanding the pathogenesis of SLE, understanding of immunological pathways that are associated with the phenotype in ... See full document

... 2.3 Clinical analysis: Laboratorial results: total cholesterol (TC), low-density lipoproteins (LDL) cholesterol, high-density lipoproteins (HDL) cholesterol, triglycerides (TG), Erythrocyte Sedimentation Rate (ESR), ... See full document

... difference in age distribution as well as disease duration between the two ...rized in table ...anemia in ANCA-positive group was obviously higher than in ANCA-negative ...often in ... See full document

... children in Australia, Canada, Germany, Korea, Qatar, Saudi Arabia, Taiwan, Uruguay, Sicily, and Madrid ...infection in immunocompromised patients [57], and effectively remains excluded from most ... See full document

... vaccination in a stable SLE population can offer protection against the ...than in- fluenza B and that in most seasons the prevalence of influenza A is higher than influenza ... See full document

... cyclophosphamide in this phase accelerates depletion of the ovarian ...encountered in the present study was the higher clinical activ- ity, measured by SLEDAI, in normally men- struating ... See full document

... role in organ involvement (Enghard et ...roles in directing cell movements necessary for the initiation of T cell immune response, attraction of appropriate effector cells to sites of inflammation and ... See full document

... used in patients without any risk of pregnancy, whose use of high dose of steroids or immuno- suppressive drugs bring many side effect without the improvement that we observed with ...problem in work or ... See full document

... 13. Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U. Inhibition of alanyl- aminopeptidase on CD4+CD25+ ... See full document

... data in the United ...(ICER) in terms of gained life years (LY) and quality of life adjusted life years ...gained. In 68% of the scenarios simulated in the PSA, belimumab was found to be a ... See full document

... identified in 22 of the 98 SLE ...patients in Tables 1 (a) and 1 (b), respec- tively. NP manifestations included (in descending order of frequency) cerebrovascular disease (7/22; 38%), generalized ... See full document

... trials in post-hoc analyses to detect the treat- ment effects in more detail, but the BLISS trials were not powered to assess these ...changes in dif- ferent measures at 52 weeks between SRI ... See full document

... formed in 1989 and currently has 16 member organisations, including the Portuguese Association of Patients with Lupus, in 15 member ...of lupus and thereby assist in im- proving the ... See full document

... Introduction. Systemic lupus erythematosus (SLE) is a systemic idiopathic autoimmune inflammatory disease, with multiple or- gan ...threatening lupus-related manifestation of the ... See full document

... outcome in survival analysis. For each patient, time (in months) from study entry to first flare event was determined and in those without flares during follow-up, observation was censored at time of ... See full document